Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Por Jernström, Sandra, Hongisto, Vesa, Leivonen, Suvi-Katri, Due, Eldri Undlien, Tadele, Dagim Shiferaw, Edgren, Henrik, Kallioniemi, Olli, Perälä, Merja, Mælandsmo, Gunhild Mari, Sahlberg, Kristine Kleivi
Publicado no Breast Cancer (Dove Med Press) (2017)

A cell competition–based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation

Por Tadele, Dagim Shiferaw, Robertson, Joseph, Crispin, Richard, Herrera, Maria C., Chlubnová, Markéta, Piechaczyk, Laure, Ayuda-Durán, Pilar, Singh, Sachin Kumar, Gedde-Dahl, Tobias, Fløisand, Yngvar, Skavland, Jørn, Wesche, Jørgen, Gjertsen, Bjørn-Tore, Enserink, Jorrit M.
Publicado no J Biol Chem (2020)